BA.2 Publications & Resources
46 results
Publication
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains James Brett Case et al.bioRxiv18 March 2022
Publication
SARS-CoV-2 Omicron potently neutralized by a novel antibody with unique Spike binding properties Craig Fenwick et al.bioRxiv18 March 2022
Publication
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines John E Bowen et al.bioRxiv16 March 2022
Publication
Omicron variant of SARS-COV-2 gains new mutations in New Zealand and Hong Kong Xiang-Jiao Yang bioRxiv15 March 2022
Publication
Development of a ferritin-based nanoparticle vaccine against the SARS-CoV-2 Omicron variant Wanbo Tai et al.bioRxiv14 March 2022
Publication
Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events Junxian Ou et al.bioRxiv14 March 2022
Publication
The Omicron SARS-CoV-2 epidemic in England during February 2022 Marc Chadeau-Hyam et al.medRxiv13 March 2022
Publication
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar Hiam Chemaitelly et al.medRxiv13 March 2022
Publication
Seroneutralization of Omicron BA.1 and BA.2 in patients receiving anti-SARS-CoV-2 monoclonal antibodies. Timothee Bruel et al.medRxiv12 March 2022
Publication
Chimeric mRNA based COVID-19 vaccine elicits potent neutralizing antibodies and protection against Omicron and Delta Qidong Hu et al.bioRxiv 7 March 2022
